Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GSDMC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LMO7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF496 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAMK2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF687 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SREBF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KMT2D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927934 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FAM83G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01580 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP3A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL1R2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDLIM7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNAB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP4F11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01554 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on